Clinical Study to Investigate the Urinary Excretion of N-nitrosodimethylamine (NDMA) After Ranitidine Administration

Clinical trial NCT04397445 · COMPLETED

Trial details

NCT number: NCT04397445
Sponsor: Food and Drug Administration (FDA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ranitidine Adverse Reaction Pharmacokinetics Food-drug Interaction

Start date: 2020-06-08
Primary completion: 2020-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.